Dyne Therapeutics, Inc. (36) | Change of Control Agreements (2)
- Amended and Restated Executive Severance and Change in Control Benefits Plan (Filed With SEC on November 3, 2022)
- Executive Severance and Change in Control Benefits Plan (Filed With SEC on August 25, 2020)
